US2006084601A1PendingUtilityA1
Method for treating respiratory distress syndrome
Est. expiryNov 14, 2020(expired)· nominal 20-yr term from priority
A61K 38/2264A61P 11/00
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides a method for treating infants, children or adults suffering from pulmonary distress caused by low or insufficient production of surfactant. It is particularly suitable for treating premature infants suffering from Respiratory Distress Syndrome. The method comprises administering a leptin compound to an individual with impaired surfactant production for a time and in an amount sufficient to enhance surfactant production. The method may be used for treatment of any mammal with impaired lung surfactant production.
Claims
exact text as granted — not AI-modified1 - 16 . (canceled)
17 . A method for regulating appetite activity in a subject comprising administering an effective dose of a non-recombinant biologically active fragment of leptin to the subject.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.